📣 VC round data is live. Check it out!

Zepp Health Valuation Multiples

Discover Zepp Health's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Viva Leisure, Vivani Medical, Emvision, Neuronetics and more.

Zepp Health Overview

About Zepp Health

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.


Founded

2014

HQ

Netherlands

Employees

765

Website

zepp.com

Financials (LTM)

Revenue: $289M
EBITDA: ($11M)

EV

$283M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Zepp Health Financials

Zepp Health reported last 12-month revenue of $289M and negative EBITDA of ($11M).

In the same LTM period, Zepp Health generated $112M in gross profit, ($11M) in EBITDA losses, and had net loss of ($23M).

Revenue (LTM)


Zepp Health P&L

In the most recent fiscal year, Zepp Health reported revenue of $259M and EBITDA of ($25M).

Zepp Health is unprofitable as of last fiscal year, with gross margin of 38%, EBITDA margin of (10%), and net margin of (15%).

See analyst estimates for Zepp Health
LTMLast FY202320242025202620272028
Revenue$289M$259M$352M$183M$259M
Gross Profit$112M$99M$93M$70M$99M
Gross Margin39%38%26%38%38%
EBITDA($11M)($25M)($19M)($47M)($25M)
EBITDA Margin(4%)(10%)(5%)(26%)(10%)
EBIT Margin(5%)(11%)(8%)(26%)(11%)
Net Profit($23M)($40M)($30M)($76M)($40M)
Net Margin(8%)(15%)(9%)(41%)(15%)
Net Debt-$170M---

Financial data powered by Morningstar, Inc.

Zepp Health Stock Performance

Zepp Health has current market cap of $111M, and enterprise value of $283M.

Market Cap Evolution


Zepp Health's stock price is $7.60.

Zepp Health share price decreased by 6.9% in the last 30 days, and increased by 185.7% in the last year.

Zepp Health has an EPS (earnings per share) of $-2.73.

See more trading valuation data for Zepp Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$283M$111M2.0%-6.9%-36.4%185.7%$-2.73

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Zepp Health Valuation Multiples

Zepp Health trades at 1.0x EV/Revenue multiple, and (24.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Zepp Health

EV / Revenue (LTM)


Zepp Health Financial Valuation Multiples

As of June 3, 2026, Zepp Health has market cap of $111M and EV of $283M.

Zepp Health has a P/E ratio of (4.9x).

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.1x0.8x1.6x1.1x
EV/EBITDA(24.9x)(11.2x)(14.9x)(6.0x)(11.2x)
EV/EBIT(20.6x)(9.7x)(9.7x)(6.0x)(9.7x)
EV/Gross Profit2.5x2.9x3.1x4.0x2.9x
P/E(4.9x)(2.8x)(3.7x)(1.5x)(2.8x)
EV/FCF-(10.7x)7.0x(10.9x)(10.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Zepp Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Zepp Health Margins & Growth Rates

Zepp Health grew revenue by 28% but EBITDA decreased by 139% in the last fiscal year.

In the most recent fiscal year, Zepp Health reported gross margin of 38%, EBITDA margin of (10%), and net margin of (15%).

See estimated margins and future growth rates for Zepp Health

Zepp Health Margins

Last FY202420252026202720282029
Gross Margin38%38%38%39%
EBITDA Margin(10%)(26%)(10%)3%
EBIT Margin(11%)(26%)(11%)2%
Net Margin(15%)(41%)(15%)0%
FCF Margin(10%)(14%)(10%)-

Zepp Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth28%(48%)42%28%
Gross Profit Growth30%(24%)41%30%
EBITDA Growth(139%)149%(47%)(139%)
EBIT Growth(126%)62%(38%)(126%)
Net Profit Growth(104%)153%(47%)(104%)
FCF Growth-(164%)2%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Zepp Health Operational KPIs

Zepp Health's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Zepp Health's Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Zepp Health's Rule of X is 73% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Zepp Health
LTMLast FY202320242025202620272028
Rule of 4019%31%---
Bessemer Rule of X53%73%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue18%21%13%25%21%
G&A Expenses to Revenue10%11%8%14%11%
R&D Expenses to Revenue14%18%14%25%18%
Opex to Revenue-50%35%64%50%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Zepp Health Competitors

Zepp Health competitors include Viva Leisure, Vivani Medical, Emvision, Neuronetics, Zomedica, JETEMA Co., SDI Group, Fonar, C-Rad and Optiscan Imaging.

Most Zepp Health public comparables operate across Wearables, Medical Devices, Fitness & Wellness, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Viva Leisure2.4x2.6x6.4x12.1x
Vivani Medical--(4.1x)-
Emvision-26.0x-(16.9x)
Neuronetics1.2x1.2x(8.4x)(10.0x)
Zomedica-1.9x--
JETEMA Co.3.7x-24.9x-
SDI Group1.7x1.5x9.2x7.7x
Fonar1.0x-5.7x-

This data is available for Pro users. Sign up to see all Zepp Health competitors and their valuation data.

Start Free Trial

Zepp Health VC Funding History

Before going public, Zepp Health raised $45M in total equity funding, across 3 rounds.

Last private valuation of Zepp Health was $57M, after raising $15M in January 2014.


Zepp Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Aug-15Series C-$25M-Zepp Health Corporation (NYSE: ZEPP), known for Amazfit smartwatches and wearables, secured early funding and a strategic partnership with Xiaomi in 2015, becoming its exclusive wearable provider, which strengthened its market position. The company originated from financing transactions noted in January 2014 and April 2015, laying groundwork for growth in health and fitness trackers. Zepp Health reporting US$102.6 million in cash and equivalents as of September 30, 2025, with Q3 2025 adjusted operating income of US$0.4 million and Q4 2025 revenue guidance of US$82-86 million, driven by products like Amazfit T-Rex 3 Pro and Bip 6.
Jan-14Series B-$15M$57MZepp Labs (now Zepp Health) develops wearable technology products. The company closed a Series B funding round on January 22, 2014, raising $15 million led by GGV Capital. The post-money valuation for the January 2014 Series B round was $56.71 million. This followed a Series A round in January 2013. Zepp Labs raised a total of $20 million across its early funding rounds. The company was later acquired on July 26, 2018.
Jan-13Series ALegend Capital$5M--

Investments by Zepp Health

Zepp Health has invested in 2 companies to date.

Latest investment by Zepp Health was on February 2nd 2023. Zepp Health invested in GreenWaves Technologies in their $21M Series B round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Zepp Health

GreenWaves Technologies
Neuro42
Description
GreenWaves Technologies is a Grenoble-based fabless semiconductor company designing ultra-low-power processors for edge AI in IoT and wearables. The firm's GAP8 processor powers image and audio analytics in battery-constrained devices, while GAP9 targets hearables with neural network acceleration. GreenWaves Technologies licenses IP to module makers, enabling deployments in smart sensors across Europe and Asia with SDK support for TensorFlow Lite.
Neuro42 is a medical technology company developing AI-enhanced MRI systems and robotic platforms for neurosurgical interventions. Mountain View-headquartered, it integrates real-time imaging with robotic precision for tumor resections and deep brain stimulation procedures. The firm's NeuroPlatform supports minimally invasive diagnostics in over 50 hospitals across North America and Europe.
HQ CountryFranceUnited States
HQ City
Grenoble
San Francisco, CA
Deal Date2 Feb 202327 Jul 2021
RoundSeries BSeries A
Raised$21M$7M
InvestorsDefinvest; InnovaCom; La French Tech; Soitec; Thales; Zepp HealthKrishna R. Bhupal; Philip Dolan; Shangbay Capital; Zepp Health
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Zepp Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Zepp Health

When was Zepp Health founded?Zepp Health was founded in 2014.
Where is Zepp Health headquartered?Zepp Health is headquartered in Netherlands.
How many employees does Zepp Health have?As of today, Zepp Health has over 765 employees.
Who is the CEO of Zepp Health?Zepp Health's CEO is Wang Wayne Huang.
Is Zepp Health publicly listed?Yes, Zepp Health is a public company listed on NYSE.
What is the stock symbol of Zepp Health?Zepp Health trades under ZEPP ticker.
When did Zepp Health go public?Zepp Health went public in 2018.
Who are competitors of Zepp Health?Zepp Health main competitors include Viva Leisure, Vivani Medical, Emvision, Neuronetics, Zomedica, JETEMA Co., SDI Group, Fonar, C-Rad, Optiscan Imaging.
What is the current market cap of Zepp Health?Zepp Health's current market cap is $111M.
What is the current revenue of Zepp Health?Zepp Health's last 12 months revenue is $289M.
What is the current revenue growth of Zepp Health?Zepp Health revenue growth (NTM/LTM) is 23%.
What is the current EV/Revenue multiple of Zepp Health?Current revenue multiple of Zepp Health is 1.0x.
Is Zepp Health profitable?No, Zepp Health is not profitable.
What is the current EBITDA of Zepp Health?Zepp Health has negative EBITDA and is not profitable.
What is Zepp Health's EBITDA margin?Zepp Health's last 12 months EBITDA margin is (4%).
What is the current EV/EBITDA multiple of Zepp Health?Current EBITDA multiple of Zepp Health is (24.9x).
How many companies Zepp Health has acquired to date?Zepp Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Zepp Health has invested to date?As of June 2026, Zepp Health has invested in 2 companies.
What was the last Zepp Health investment?On 2nd February 2023 Zepp Health invested in GreenWaves Technologies, participating in a $21M Series B round, alongside Definvest, InnovaCom, La French Tech, Soitec, and Thales.
In what companies Zepp Health invested in?Zepp Health invested in GreenWaves Technologies and Neuro42.

See public comps similar to Zepp Health

Lists including Zepp Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial